Clinical Trials on High-risk Percutaneous Coronary Intervention in Hong Kong
Total 20 results
-
Chinese University of Hong KongRecruiting
-
Prof. Stephen LeePfizer; Queen Mary Hospital, Hong KongCompletedCoronary Disease | Hydroxymethylglutaryl-CoA Reductase Inhibitors | Ultrasonography, InterventionalChina
-
Duke UniversityAcist Medical SystemsCompletedPercutaneous Coronary InterventionUnited States
-
Samsung Medical CenterCompletedPercutaneous Coronary Intervention | Erythrocyte Transfusion | RevascularizationKorea, Republic of
-
Samsung Medical CenterCompletedPercutaneous Coronary Intervention | Erythrocyte Transfusion | RevascularizationKorea, Republic of
-
The University of Hong KongHong Kong Jockey Club Charities Trust; Lok Sin Tong Benevolent Society, Kowloon and other collaboratorsRecruitingHypertension | Diabetes Mellitus, Type 2 | Medication Adherence | Polypharmacy | Medication Safety | High Risk MedicationsHong Kong
-
CathWorks Ltd.Cardiovascular Research Foundation, New YorkRecruitingPercutaneous Coronary InterventionUnited States, Israel
-
Samsung Medical CenterCompletedAdherence, Medication | Percutaneous Coronary Intervention | Compliance, Medication | Platelet Aggregation Inhibitors | Hydroxymethylglutaryl-coa Reductase Inhibitors | Persistence, MedicationKorea, Republic of
-
Jesse Brown VA Medical CenterUnknownPercutaneous Coronary Intervention | Optical Coherence Tomography | In-stent Coronary Artery RestenosisUnited States
-
Boehringer IngelheimCompletedAtrial Fibrillation | Percutaneous Coronary InterventionCanada, United States, Spain, Korea, Republic of, Australia, Germany, Taiwan, Hong Kong, Thailand, United Kingdom, Turkey, Netherlands, Ireland, Hungary, Croatia, Colombia, Israel, Singapore, Italy, New Zealand, Greece, Mexico, Norway, Swed... and more
-
AstraZenecaCompletedAcute Coronary Syndrome | Percutaneous Coronary InterventionKorea, Republic of, Japan, Taiwan
-
Brigham and Women's HospitalNational Institute of Mental Health (NIMH); Yale University; OrygenRecruitingPsychosis | Remission | Conversion | Clinical High RiskUnited States, United Kingdom, Canada, Italy, Australia, Chile, China, Denmark, Germany, Hong Kong, Korea, Republic of, Singapore, Spain, Switzerland
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
-
Jazz PharmaceuticalsThe Leukemia and Lymphoma SocietyCompletedHigh Risk Acute Myeloid LeukemiaUnited States, Canada
-
Advaxis, Inc.Gynecologic Oncology GroupTerminatedHigh Risk Cervical Cancer | Advanced Cervical CancerUnited States, Argentina, Brazil, Canada, Chile, Korea, Republic of, Malaysia, Mexico, Poland, Russian Federation, Serbia, Spain, Taiwan, Ukraine
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingRecurrent Neuroblastoma | Refractory Neuroblastoma | High Risk NeuroblastomaUnited States, Canada, Puerto Rico, Australia, New Zealand
-
AstraZenecaThe Cleveland Clinic; IQVIA RDS Inc.CompletedEligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)United States, Belgium, Italy, Netherlands, Denmark, Taiwan, Poland, Russian Federation, Korea, Republic of, Hungary, United Kingdom, China, New Zealand, Czechia, Australia, South Africa, Ukraine, Japan, Canada, Mexico, Lithuania, Estoni...
-
AstraZenecaBristol-Myers Squibb; Hadassah Medical Organization; The TIMI Study GroupCompletedDiabetes Mellitus, Non-Insulin-Dependent | High Risk for Cardiovascular EventUnited States, Canada, France, Italy, Netherlands, Spain, Belgium, Thailand, Vietnam, Bulgaria, Korea, Republic of, Brazil, Philippines, Russian Federation, Turkey, Taiwan, Australia, Israel, South Africa, Germany, Japan, Czechia, H... and more
-
Eisai Inc.Thrombolysis In Myocardial Infarction (TIMI) Academic Research OrganizationCompletedObesity | Cardiovascular Disease | Overweight | Type 2 Diabetes | High Cardiovascular RiskUnited States, Canada, Poland, Australia, Mexico, New Zealand, Bahamas, Chile
-
BayerRecruitingAcute Non-cardioembolic Ischemic Stroke | Prevention of Ischemic Stroke | High-risk Transient Ischemic AttackUnited States, Switzerland, Belgium, Sweden, Canada, Australia, Taiwan, Spain, Korea, Republic of, Latvia, Israel, Malaysia, Greece, Japan, Turkey, Netherlands, Romania, China, United Kingdom, Portugal, Italy, Brazil, France, Slovakia, ... and more